Cellular and molecular mechanisms of oxidants and antioxidants

Mineral and Electrolyte Metabolism

Volumn 23, Issue 3-6, 1997, Pages 135-139

  Traber, Maret G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Kidney; NF B; Peroxide; Superoxide; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; FREE RADICAL; GLUTATHIONE; REACTIVE OXYGEN METABOLITE;

ALPHA TOCOPHEROL DEFICIENCY; ATHEROSCLEROSIS; CONFERENCE PAPER; GENETIC DISORDER; HUMAN; KIDNEY DISEASE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VITAMIN BLOOD LEVEL;

EID: 0030716851     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (68)

1. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. Oxford, Clarendon, 1989.
2. Fuchs J: Oxidative injury in dermatopathology. New York, Springer, 1992.
3. Thomas JP, Maiorino M, Rusini R, Girotti AW: Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation: In situ reduction of phospholipid and cholesterol hydroperoxides. J Biol Chem 1990;265:454-461.
4. Meister A: Metabolism and function of glutathione; in Dolphin D, Poulson R, Avrannovic O (eds): Glutathione. New York, Wiley, 1989, pp 367-474.
5. Miura K, Ishii T, Sugita Y, Bannai S: Cystine uptake and glutathione level in endothelial cells exposed to oxidative stress. Am J Physiol 1992;262: C50-58.
6. Deneke SM: Induction of cystine transport in bovine pulmonary artery endothelial cells by sodium arsenite. Biochim Biophys Acta 1992;1109:127-131.
7. Cotgreave IA, Schuppe-Koistinen I: A role for gamma-glutamyl transpeptidase in the transport of cystine into human endothelial cells: Relationship to intracellular glutathione. Biochim Biophys Acta 1994;1222:375-382.
8. Packer L: Vitamin E is nature's master antioxidant. Sci Am Sci Med 1994;l:54-63.
9. Tappel AL: Vitamin E as the biological lipid antioxidant. Vitam Horm 1962;20:493-510.
10. Burton GW, Ingold KU: Vitamin E: Application of the principles of physical organic chemistry to the exploration of its structure and function. Acc Chem Res 1986;19:194-201.
11. Burton GW, Joyce A, Ingold KU: Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes? Arch Biochem Biophys 1983;221:281-290.
12. Ingold KU, Webb AC, Witter D, Burton GW, Metcalfe TA, Muller DPR: Vitamin E remains the major lipid-soluble, chain-breaking antioxidant in human plasma even in individuals suffering severe vitamin E deficiency. Arch Biochem Biophys 1987;259:224-225.
13. Burton GW, Doha T, Gabe EJ, Hughes L, Lee FL, Prasad L, Ingold KU: Autoxidation of biological molecules. 4. Maximizing the antioxidant activity of phenols. J Am Chem Soc 1985;107:7053-7065.
14. Wefers H, Sies H: The protection by ascorbate and glutathione against microsomal lipid peroxidation is dependent on vitamin E. Eur J Biochem 1988;174:353-357.
15. McCay PB: Vitamin E: Interactions with free radicals and ascorbate. Annu Rev Nutr 1985;5:323-340.
16. Niki E: Antioxidants in relation to lipid peroxidation. Chem Phys Lipids 1987;44:227-253.
17. Sies H, Murphy ME: Role of tocopherols in the protection of biological systems against oxidative damage. Photochem Photobiol 1991;8:211-224.
18. Sies H, Stahl W, Sundquist AR: Antioxidant functions of vitamins (vitamins E and C, beta-carotene, and other carotenoids). Ann NY Acad Sci 1992;669:7-20.
19. Lewis LA, Quaife ML, Page IH: Lipoproteins of serum, carriers of tocopherol. Am J Physiol 1954;178:221-222.
20. McCormick EC, Cornwell DG, Brown JB: Studies on the distribution of tocopherol in human serum lipoproteins. J Lipid Res 1960;1:221-228.
21. Traber MG, Sies H: Vitamin E in humans: Demand and delivery. Annu Rev Nutr 1996;16:321-347.
22. Traber MG, Rudel LL, Burton GW, Hughes L, Ingold KU, Kayden HJ: Nascent VLDL from liver perfusions of cynomologus monkeys are preferentially enriched in RRR- compared with SRR-α tocopherol: Studies using deuterated tocopherols. J Lipid Res 1990;31:687-694.
23. Traber MG, Ramakrishnan R, Kayden HJ: Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-α-tocopherol. Proc Natl Acad Sci USA 1994;91:10005-10008.
24. Sato Y, Hagiwara K, Araï H, Inoue K: Purification and characterization of α-tocopherol transfer protein from rat liver. FEBS Lett 1991;288:41-45.
25. Yoshida H, Yusin M, Ren I, Kuhlenkamp J, Hirano T, Stolz A, Kaplowitz N: Identification, purification and immunochemical characterization of a tocopherol-binding protein in rat liver cytosol. J Lipid Res 1992;33:343-350.
26. Kuhlenkamp J, Ronk M, Yusin M, Stolz A, Kaplowitz N: Identification and purification of a human liver cytosolic tocopherol binding protein. Prot Exp Purifie 1993;4:382-389.
27. Arita M, Sato Y, Miyata A, Tanabe T, Takahashi E, Kayden H, Arai H, Inoue K: Human alphatocopherol transfer protein: cDNA cloning, expression and chromosomal localization. Biochem J 1995;306:437-443.
28. Sato Y, Arai H, Miyata A, Tokita S, Yamamoto K, Tanabe T, Inoue K: Primary structure of alphatocopherol transfer protein from rat liver: Homology with cellular retinaldehyde-binding protein. J Biol Chem 1993;268:17705-17710.
29. Ben Hamida M, Belal S, Sirugo G, Ben Hamida C, Panayides K, Ionannou P, Beckmann J, Mandel JL, Hentati F, Koenig M, Middleton L: Friedreich's ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamine E deficiency in two inbred tunisian families. Neurology 1993;43:2179-2183.
30. Ben Hamida C, Doerflinger N, Belal S, Linder C, Reutenauer L, Dib C, Gyapay G, Bignal A, Le Paslier D, Cohen D, Pandolfo M, Mokini V, Novelli G, Hentati F, Ben Hamida M, Mandel JL, Koenig M: Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping. Nat Genet 1993;5: 195-200.
31. Sokol RJ, Kayden HJ, Bettis DB, Traber MG, Neville H, Ringel S, Wilson WB, Stumpf DA: Isolated vitamin E deficiency in the absence of fat malabsorption - Familial and sporadic cases. Characterization and investigation of causes. J Lab Clin Med 1988;111:548-559.
32. Traber MG, Sokol RJ, Burton GW, Ingold KU, Papas AM, Huffaker JE, Kayden HJ: Impaired ability of patients with familial isolated vitamin E deficiency to incorporate α-tocopherol into lipoproteins secreted by the liver. J Clin Invest 1990;85:397-407.
33. Traber MG, Sokol RJ, Kohlschütter A, Yokota T, Muller DPR, Dufour R, Kayden HJ: Impaired discrimination between stereoisomers of α-tocopherol in patients with familial isolated vitamin E deficiency. J Lipid Res 1993;34:201-210.
34. Traber MG: Regulation of human plasma vitamin E; in Sies H (ed): Antioxidants in Disease Mechanisms and Therapeutic Strategies. San Diego, Academic Press, 1996, vol. 38, pp 49-63.
35. Gotoda T, Arita M, Arai H, Inoue K, Yokota T, Fukuo Y, Yazaki Y, Yamada N: Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein. N Engl J Med 1995;333:1313-1318.
36. Dutta-Roy A, Gordon M, Leishman D, Paterson BJ, Duthie GG, James WPT: Purification and partial characterization of an alpha-tocopherol-binding protein from rabbit heart cytosol. Mol Cell Biochem 1993;123:139-144.
37. Dutta-Roy AK, Leishman DJ, Gordon MJ, Campbell FM, Duthie GG: Identification of a low molecular mass (14.2 kDa) alpha-tocopherol-binding protein in the cytosol of rat liver and heart. Biochem Biophys Res Commun 1993;196:1108-1112.
38. Gordon MJ, Campbell FM, Duthie GG, Dutta-Roy AK: Characterization of a novel alpha-tocopherol-binding protein from bovine heart cytosol. Arch Biochem Biophys 1995;318:140-146.
39. Nalecz K, Nalecz M, Azzi A: Isolation of tocopherol-binding proteins from the cytosol of smooth muscle A7R5 cells. Eur J Biochem 1992;209:37-42.
40. Podda M, Weber C, Traber MG, Packer L: Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols and ubiquinones. J Lipid Res 1996;37:893-901.
41. Burton GW, Joyce A, Jngold KU: First proof that vitamin E is major lipid-soluble, chain-breaking antioxidant in human blood plasma. Lancet 1982;ii:327.
42. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.
43. Jialal I, Fuller CJ, Huet BA: The effect of α-tocopherol supplementation on LDL oxidation: A doseresponse study. Arterioscler Thromb Vasc Biol 1995;15:190-198.
44. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willet WC: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-1456.
45. Stampfer MJ, Hennekens C, Manson JE, Colditz GA, Rosner B, Willet WC: Vitamin E consumption and risk of coronary disease in women. N Engl J Med 1993;328:1444-1449.
46. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ: Randomised controlled trial of vitamin E in patients with coronary disease - Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-786.
47. Regnstrom J, Nilsson J, Moldeus P, Strom K, Bavenholm P, Tornvall P, Hamsten A: Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease. Am J Clin Nutr 1996;63:377-385.
48. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141-179.
49. Baldwin AS: The NF-κB and IκB proteins: New discoveries and insights. Annu Rev Immunol 1996;14:649-681.
50. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T: Signal induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev 1995;9:1586-1597.
51. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S: Rel/NF-kappa B/I kappa B family: Intimate tales of association and dissociation. Genes Dev 1995;9:2723-2735.
52. Schulze-Osthoff K, Beyaert R, Vandevoorde V, Haegeman G, Fiers W: Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 1993;12: 3095-3104.
53. Hayashi T, Ueno Y, Okamoto T: Oxidoreductive regulation of nuclear factor kappa B: Involvement of a cellular reducing catalyst thioredoxin. J Biol Chem 1993;268:11380-11388.
54. Meyer M, Pahl HL, Baeuerle PA: Regulation of the transcription factors NF-kappa B and AP-1 by redox changes. Chem Biol Interact 1994;91:91-100.
55. Groene EF, Walli AK, Groene HJ, Miller B, Seidel D: The role of lipids in nephrosclerosis and glomerulosclerosis. Atherosclerosis 1994;107:1-13.
56. Wheeler DC, Chana RS: Interaction between lipoproteins, glomerular cells and matrix. Miner Electrolyte Metab 1993;19:149-164.
57. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS: Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995;41:1135-1138.
58. Visarius TM, Putt DA, Schare JM, Pegouske DM, Lash LH: Pathways of glutathione metabolism and transport in isolated proximal tubular cells from rat kidney. Biochem Pharmacol 1996;52:259-272.
59. Yi JR, Lu S, Fernandez-Checa J, Kaplowitz N: Expression cloning of a rat hepatic reduced glutathione transporter with canalicular characteristics. J Clin Invest 1994;93:1841-1845.
60. Baud L, Ardaillou R: Involvement of reactive oxygen species in kidney damage. Br Med Bull 1993;49:621-629.
61. Kurosaki M, Li Calzi M, Scanziani E, Garattini E, Terao M: Tissue- and cell-specific expression of mouse xanthine oxidoreductase gene in vivo: Regulation by bacterial lipopolysaccharide. Biochem J 1995;306:225-234.
62. Linas SL, Whittenburg D, Repine JE: Role of xanthine oxidase in ischemia/reperfusion injury. Am J Physiol 1990;258:F711-F716.
63. Pryor WA, Squadrito GL: The chemistry of peroxynitrite: A product from the reaction of nitric oxide with Superoxide. Am J Physiol 1995;268:L699-L722.
64. Bank N: Renal hemodynamic consequence of hyperlipidemia. Miner Electrolyte Metab 1993;19: 165-172.
65. Peer G, Blum M, Iaina A: Nitric oxide and acute renal failure. Nephron 1996;73:375-381.
66. Kunz D, Walker G, Eberhardt W, Nitsch D, Pfeilschifter J: Interleukin 1-beta-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A. Biochem Biophys Res Commun 1995;216:438-446.
67. Muraoka KI, Fujimoto K, Sun X, Yoshioka K, Shimizu KI, Yagi M, Bose HJ, Miyazaki I, Yamamoto KI: Immunosuppressant FK506 induces interleukin-6-production through the activation of transcription factor nuclear factor (NF)-κB: Implications for Fk506 nephropathy. J Clin Invest 1996;97:2433-2439.
68. Baud L, Ardaillou R: Tumor necrosis factor in renal injury. Miner Electrolyte Metab 1995;21:336-341.